Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial

por Merchante, Nicolás, Cárcel, Sheila, Garrido-Gracia, José Carlos, Trigo-Rodríguez, Marta, Moreno, María Ángeles Esteban, León-López, Rafael, Espíndola-Gómez, Reinaldo, Alonso, Eduardo Aguilar, García, David Vinuesa, Romero-Palacios, Alberto, Pérez-Camacho, Inés, Gutiérrez-Gutiérrez, Belén, Martínez-Marcos, Francisco Javier, Fernández-Roldán, Concepción, Pérez-Crespo, Pedro María Martínez, Caño, Alexandra Aceituno, León, Eva, Corzo, Juan E., de la Fuente, Carmen, Torre-Cisneros, Julián
Publicado 2022

Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial

por Trigo-Rodríguez, Marta, Cárcel, Sheila, Navas, Ana, Espíndola-Gómez, Reinaldo, Garrido-Gracia, José Carlos, Esteban Moreno, María Ángeles, León-López, Rafael, Pérez-Crespo, Pedro María Martínez, Alonso, Eduardo Aguilar, Vinuesa, David, Romero-Palacios, Alberto, Pérez-Camacho, Inés, Gutiérrez-Gutiérrez, Belén, Martínez-Marcos, Francisco Javier, Fernández-Roldán, Concepción, León, Eva, Caño, Alexandra Aceituno, Corzo-Delgado, Juan E, Perez-Nadales, Elena, Riazzo, Cristina, de la Fuente, Carmen, Jurado, Aurora, Torre-Cisneros, Julián, Merchante, Nicolás
Publicado 2023